Importantly, when combined with a CD47 nanobody, IR700@Nb289‐OMVs markedly extended survival and partially eradicated tumours in subcutaneous and metastatic (lung and peritoneal cavity) CRC mouse models. Here, CD47 is linked to colorectal carcinoma.